
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32899525</article-id><article-id pub-id-type="pmc">7570867</article-id><article-id pub-id-type="doi">10.3390/molecules25184058</article-id><article-id pub-id-type="publisher-id">molecules-25-04058</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Retrofractamide C Derived from <italic>Piper longum</italic> Alleviates Xylene-Induced Mouse Ear Edema and Inhibits Phosphorylation of ERK and NF-&#x003ba;B in LPS-Induced J774A.1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lim</surname><given-names>Hyung Jin</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04058">1</xref><xref ref-type="aff" rid="af2-molecules-25-04058">2</xref></contrib><contrib contrib-type="author"><name><surname>Bak</surname><given-names>Seon Gyeong</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04058">1</xref><xref ref-type="aff" rid="af3-molecules-25-04058">3</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Eun Jae</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04058">1</xref><xref ref-type="aff" rid="af4-molecules-25-04058">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1269-3804</contrib-id><name><surname>Ku</surname><given-names>Sae-Kwang</given-names></name><xref ref-type="aff" rid="af5-molecules-25-04058">5</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Soyoung</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04058">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1025-7363</contrib-id><name><surname>Lee</surname><given-names>Seung Woong</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04058">1</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Kang Min</given-names></name><xref ref-type="aff" rid="af2-molecules-25-04058">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1908-7666</contrib-id><name><surname>Lee</surname><given-names>Seung-Jae</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04058">1</xref><xref rid="c1-molecules-25-04058" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Rho</surname><given-names>Mun-Chual</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04058">1</xref><xref rid="c1-molecules-25-04058" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-molecules-25-04058"><label>1</label>Immunoregulatory Material Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Jeonbuk 56212, Korea; <email>lhjin@kribb.re.kr</email> (H.J.L.); <email>tsk9096@kribb.re.kr</email> (S.G.B.); <email>pej911029@kribb.re.kr</email> (E.J.P.); <email>sylee@kribb.re.kr</email> (S.L.); <email>lswdoc@kribb.re.kr</email> (S.W.L.)</aff><aff id="af2-molecules-25-04058"><label>2</label>Department of Molecular Biology, Chonbuk National University, Jeonju-si, Jeonbuk 54896, Korea; <email>kmlee@jbnu.ac.kr</email></aff><aff id="af3-molecules-25-04058"><label>3</label>Department of Marine Bio Food Science, Chonnam National University, Yeosu-si, Jeonnam 59626, Korea</aff><aff id="af4-molecules-25-04058"><label>4</label>Division of Biotechnology and Advanced Institute of Environment and Bioscience, Jeonbuk National University, Iksan-si, Jeonbuk 54596, Korea</aff><aff id="af5-molecules-25-04058"><label>5</label>Department of Anatomy and Histology, College of Korean Medicine, Daegu Haany University, Gyeongsan-si, Gyeonbuk 38610, Korea; <email>gucci200@hanmail.net</email></aff><author-notes><corresp id="c1-molecules-25-04058"><label>*</label>Correspondence: <email>seung99@kribb.re.kr</email> (S.-J.L.); <email>rho-m@kribb.re.kr</email> (M.-C.R.); Tel.: +82-63-570-5267 (S.-J.L.); +82-63-570-5230 (M.-C.R.)</corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2020</year></pub-date><volume>25</volume><issue>18</issue><elocation-id>4058</elocation-id><history><date date-type="received"><day>11</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>03</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Many studies have reported the biological activities of retrofractamide C (RAC). However, few studies have investigated the anti-inflammatory effect of RAC. In the present study, we investigated the anti-inflammatory effect of RAC using lipopolysaccharide (LPS)-induced J774A.1 cells and a xylene-induced mouse ear edema model. Treatment with RAC decreased LPS-induced nitric oxide (NO) and prostaglandin E2 (PGE2) secretion and inducible NO synthase (iNOS) and cyclooxygenase 2 (COX2) protein expression. It also downregulated the LPS-induced production of interleukin-1&#x003b2; (IL-1&#x003b2;) and interleukin-6 (IL-6) but not tumor necrosis factor &#x003b1; (TNF-&#x003b1;). In the LPS-induced signaling pathway, RAC inhibited the phosphorylation of extracellular signal-regulated kinase (ERK) and nuclear factor kappa light chain enhancer of activated B cells (NF-&#x003ba;B) but not c-Jun N-terminal kinase (JNK) or p38. In a xylene-induced mouse ear edema model, RAC treatment alleviated edema formation and inflammatory cell infiltration. In conclusion, the present study indicates that RAC has the potential to have anti-inflammatory effects and could be a prospective functional food.</p></abstract><kwd-group><kwd><italic>Piper longum</italic></kwd><kwd>retrofractamide C</kwd><kwd>xylene-induced ear edema</kwd><kwd>anti-inflammation</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-25-04058"><title>1. Introduction</title><p>The role of the inflammatory response is to defend the body against infection and tissue injury [<xref rid="B1-molecules-25-04058" ref-type="bibr">1</xref>,<xref rid="B2-molecules-25-04058" ref-type="bibr">2</xref>,<xref rid="B3-molecules-25-04058" ref-type="bibr">3</xref>]. The inflammatory response is initiated by recognition of pathogen-associated molecular patterns (PAMPs) of foreign substances or damage-associated molecular patterns (DAMPs) of injured tissue by pattern recognition receptors (PRRs) of residing or circulating immune cells, such as macrophages, mast cells, fibroblasts and leukocytes [<xref rid="B3-molecules-25-04058" ref-type="bibr">3</xref>,<xref rid="B4-molecules-25-04058" ref-type="bibr">4</xref>]. Toll-like receptor (TLR) family members are PRRs that detect various molecules, such as extracellular components and nucleic acids of bacteria and viruses, according to their subtype [<xref rid="B5-molecules-25-04058" ref-type="bibr">5</xref>,<xref rid="B6-molecules-25-04058" ref-type="bibr">6</xref>]. Once a PRR binds its agonist, downstream signaling pathways, including mitogen-activated protein kinases (MAPKs) and the nuclear factor kappa light chain enhancer of activated B cells (NF-&#x003ba;B) signaling pathway, are activated. Subsequently, activator protein-1 (AP-1), which is activated by MAPKs, and NF-&#x003ba;B upregulate proinflammatory gene expression [<xref rid="B5-molecules-25-04058" ref-type="bibr">5</xref>,<xref rid="B6-molecules-25-04058" ref-type="bibr">6</xref>,<xref rid="B7-molecules-25-04058" ref-type="bibr">7</xref>,<xref rid="B8-molecules-25-04058" ref-type="bibr">8</xref>]. The inflammatory response is mediated and maintained by upregulated proinflammatory cytokines and chemokines. The response induces immune cells to remove pathogenic factors but is often accompanied by pain, vasodilation and fever [<xref rid="B9-molecules-25-04058" ref-type="bibr">9</xref>,<xref rid="B10-molecules-25-04058" ref-type="bibr">10</xref>]. Thus, acute and chronic inflammatory responses can cause inflammatory diseases, such as sepsis, ulcerative colitis, rheumatoid arthritis and asthma [<xref rid="B11-molecules-25-04058" ref-type="bibr">11</xref>,<xref rid="B12-molecules-25-04058" ref-type="bibr">12</xref>,<xref rid="B13-molecules-25-04058" ref-type="bibr">13</xref>,<xref rid="B14-molecules-25-04058" ref-type="bibr">14</xref>].</p><p>There are various models to evaluate the anti-inflammatory activities of natural products. The LPS-induced macrophages are commonly used as an in vitro model to access anti-inflammatory activity. LPS stimulated macrophages to produce proinflammatory cytokines and chemokines such as IL-1&#x003b2;, IL-6, IL-8 and monocyte chemoattractant protein 1 (MCP-1) [<xref rid="B15-molecules-25-04058" ref-type="bibr">15</xref>]. The severity of inflammation is evaluated by proinflammatory mediators and an anti-inflammatory mechanism is accessed through LPS-induced signaling pathways such as MAPKs and NF-&#x003ba;B. Xylene-induced mouse ear edema model is a simple and widely used animal model for accessing the anti-inflammatory activity of natural products. ICR mouse, which is used in this study, is an albino outbred stain and has been widely used in various research fields, such as pharmacology, toxicology and oncology. It shows an inflammatory response against various stimuli like xylene, formalin, carrageenan and LPS [<xref rid="B16-molecules-25-04058" ref-type="bibr">16</xref>]. Xylene application on skin results in an increase in oxidative species and DNA fragmentation [<xref rid="B17-molecules-25-04058" ref-type="bibr">17</xref>,<xref rid="B18-molecules-25-04058" ref-type="bibr">18</xref>]. It induces iNOS and TNF-&#x003b1; in the skin. Xylene also causes a histopathological change in the skin. For example, swelling, immune cell infiltration and stratum corneum destruction are induced [<xref rid="B19-molecules-25-04058" ref-type="bibr">19</xref>].</p><p><italic>Piper longum</italic> L., also called long pepper, is widely cultivated in the tropical and subtropical regions of the world [<xref rid="B20-molecules-25-04058" ref-type="bibr">20</xref>,<xref rid="B21-molecules-25-04058" ref-type="bibr">21</xref>]. The fruits of <italic>Piper longum</italic> are commonly used as spices and traditional medicines to treat chronic bronchitis, cough, cold and poisonous snake bites [<xref rid="B22-molecules-25-04058" ref-type="bibr">22</xref>]. Various biological properties, such as antioxidative, insecticidal, antimicrobial, antitumor and anti-inflammatory properties, have been reported [<xref rid="B23-molecules-25-04058" ref-type="bibr">23</xref>,<xref rid="B24-molecules-25-04058" ref-type="bibr">24</xref>,<xref rid="B25-molecules-25-04058" ref-type="bibr">25</xref>]. The phytochemical constituents of fruits of <italic>Piper longum</italic> are known to be terpenes, lignans, flavones and alkaloids [<xref rid="B26-molecules-25-04058" ref-type="bibr">26</xref>]. In a previous study, we isolated three alkamides, including retrofractamide C (RAC), from fruits of <italic>Piper longum</italic> and reported the inhibitory effect on diacylglycerol acyltransferase and cell adhesion [<xref rid="B27-molecules-25-04058" ref-type="bibr">27</xref>,<xref rid="B28-molecules-25-04058" ref-type="bibr">28</xref>]. It is also reported that RAC activates transient receptor potential vanilloid 1 (TRPV1), which is associated with anti-inflammation and anticancer [<xref rid="B29-molecules-25-04058" ref-type="bibr">29</xref>]. However, the anti-inflammatory activity of RAC has been poorly studied.</p><p>In this study, we investigated the anti-inflammatory activity of RAC on LPS-induced J774A.1 cells and its therapeutic effect against xylene-induced mouse ear edema acute inflammation model.</p></sec><sec sec-type="results" id="sec2-molecules-25-04058"><title>2. Results and Discussion</title><sec id="sec2dot1-molecules-25-04058"><title>2.1. RAC Inhibits NO and PGE2 Production in LPS-Induced J774A.1 Cells</title><p>NO and PGE2 are major mediators of the inflammatory response. Their biosynthesis is significantly upregulated in inflamed regions, and they contribute to the pathogenesis of inflammatory disorders [<xref rid="B30-molecules-25-04058" ref-type="bibr">30</xref>,<xref rid="B31-molecules-25-04058" ref-type="bibr">31</xref>]. NO is produced by NO synthase (NOS) and converted from L-arginine in the presence of NADPH and oxygen. In this process, tetrahydrobiopterin (BH4), flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN) and heme act as a cofactor [<xref rid="B32-molecules-25-04058" ref-type="bibr">32</xref>]. PGE2 synthesis is initiated with arachidonic acid formation from phospholipids of the cell membrane by phospholipase A2 (PLA2). Arachidonic acid is converted to prostaglandin H 2 (PGH2) by cyclooxygenase (COX) then, PGH2 is converted to PGE2 by PGE2 synthase [<xref rid="B33-molecules-25-04058" ref-type="bibr">33</xref>]. NO and PGE productions are regulated by substrates availability, enzyme expressions and enzyme activities. Previous studies showed that reducing NO and PGE2 levels could reduce the symptoms of inflammatory diseases [<xref rid="B30-molecules-25-04058" ref-type="bibr">30</xref>,<xref rid="B31-molecules-25-04058" ref-type="bibr">31</xref>,<xref rid="B32-molecules-25-04058" ref-type="bibr">32</xref>,<xref rid="B33-molecules-25-04058" ref-type="bibr">33</xref>,<xref rid="B34-molecules-25-04058" ref-type="bibr">34</xref>]. Before investigating the anti-inflammatory effect of RAC (<xref ref-type="fig" rid="molecules-25-04058-f001">Figure 1</xref>A), an MTT assay for the cytotoxicity of RAC was performed. There was no cytotoxicity on J774A.1 cells at the indicated concentration of RAC (<xref ref-type="fig" rid="molecules-25-04058-f001">Figure 1</xref>B). After that, we investigated the effect of RAC on LPS-induced NO and PGE2 production to evaluate the anti-inflammatory effect of RAC. RAC treatment inhibited both NO and PGE2 production in a dose-dependent manner (<xref ref-type="fig" rid="molecules-25-04058-f001">Figure 1</xref>C, D).</p></sec><sec id="sec2dot2-molecules-25-04058"><title>2.2. RAC Decreases iNOS and COX2 Expression in LPS-Induced J774A.1 Cells</title><p>The synthesis of NO and PGE2 is achieved by NOS and COX enzymes. They have several isotype enzymes; however, specific enzymes, iNOS and COX2, are responsible for NO and PGE2 production in the inflammatory response [<xref rid="B30-molecules-25-04058" ref-type="bibr">30</xref>,<xref rid="B31-molecules-25-04058" ref-type="bibr">31</xref>,<xref rid="B32-molecules-25-04058" ref-type="bibr">32</xref>]. Inhibition of their activity and expression reduces NO and PGE2 levels and could alleviate inflammatory disorders [<xref rid="B31-molecules-25-04058" ref-type="bibr">31</xref>,<xref rid="B32-molecules-25-04058" ref-type="bibr">32</xref>]. To determine whether RAC affected LPS-induced iNOS and COX2 protein expressions, immunoblot assay was performed. iNOS expression was significantly decreased after 3 and 10 &#x003bc;M RAC treatment, and COX2 expression was significantly downregulated after 10 &#x003bc;M RAC treatment (<xref ref-type="fig" rid="molecules-25-04058-f001">Figure 1</xref>E). There are several factors, which regulated both iNOS and COX2 expressions, including transforming growth factor &#x003b2; (TGF-&#x003b2;), NF-&#x003ba;B and AP-1. In macrophage cells, TGF-&#x003b2; inhibits COX2 expression and it increases degradation of iNOS and decreases iNOS mRNA stability [<xref rid="B32-molecules-25-04058" ref-type="bibr">32</xref>,<xref rid="B33-molecules-25-04058" ref-type="bibr">33</xref>]. The expressions of iNOS and COX2 are also regulated by NF- &#x003ba;B and AP-1, which are transcriptional factors. Thus, RAC treatment could affect these factors and downregulation of iNOS and COX2 protein expressions.</p></sec><sec id="sec2dot3-molecules-25-04058"><title>2.3. RAC Inhibits IL-1&#x003b2; and IL-6 But Not TNF-&#x003b1; Gene Expression in LPS-Induced J774A.1 Cells</title><p>Proinflammatory cytokines induced by activated innate immune cells mediate and amplify the inflammatory response through activation of their downstream signaling cascades [<xref rid="B34-molecules-25-04058" ref-type="bibr">34</xref>,<xref rid="B35-molecules-25-04058" ref-type="bibr">35</xref>]. They are also related to the pathogenesis and hyperalgesia of inflammatory disorders [<xref rid="B36-molecules-25-04058" ref-type="bibr">36</xref>,<xref rid="B37-molecules-25-04058" ref-type="bibr">37</xref>,<xref rid="B38-molecules-25-04058" ref-type="bibr">38</xref>]. The effect of RAC on proinflammatory cytokine expression was evaluated by quantitative real-time PCR. As shown, LPS-induced IL-1&#x003b2; and IL-6 expression was significantly decreased after 3 and 10 &#x003bc;M RAC treatment, but TNF-&#x003b1; expression was not affected (<xref ref-type="fig" rid="molecules-25-04058-f002">Figure 2</xref>). Regulation of these cytokine gene expressions is affected by various factors. LPS stimulation leads to activation of transcription factors such as NF-&#x003ba;B, AP-1, IRF and CCAAT/enhancer-binding protein &#x003b2; (C/EBP&#x003b2;) and they promote proinflammatory cytokine gene expressions [<xref rid="B39-molecules-25-04058" ref-type="bibr">39</xref>]. The cytokine mRNA is controlled by post-transcriptional regulation. Binding of RNA binding proteins or microRNA with cytokine mRNA decreases RNA stability and increases mRNA degradations [<xref rid="B40-molecules-25-04058" ref-type="bibr">40</xref>].</p></sec><sec id="sec2dot4-molecules-25-04058"><title>2.4. RAC Decreases Phosphorylated ERK and NF-&#x003ba;B p65 But Not JNK or p38 in LPS-Induced J774A.1 Cells</title><p>MAPKs and NF-&#x003ba;B signaling are involved in the TLR family signaling pathway, as part of the downstream signaling cascade [<xref rid="B5-molecules-25-04058" ref-type="bibr">5</xref>,<xref rid="B6-molecules-25-04058" ref-type="bibr">6</xref>]. Inhibition of these signaling molecules is a good strategy to treat inflammatory diseases. To investigate the effect of RAC on MAPKs and NF-&#x003ba;B signaling molecules, immunoblot analysis was performed. The results showed that RAC treatment downregulated the phosphorylation of ERK and NF-&#x003ba;B p65 (<xref ref-type="fig" rid="molecules-25-04058-f003">Figure 3</xref>A,B). However, it did not affect the phosphorylation of JNK and p38 (<xref ref-type="fig" rid="molecules-25-04058-f003">Figure 3</xref>A). These results indicate that RAC selectively regulates signaling molecules, ERK and NF-&#x003ba;B. There are some studies showing that selective inhibition of ERK and NF-&#x003ba;B could not affect the production of TNF-&#x003b1; but decreased other inflammatory mediators, such as IL-1&#x003b2;, IL-6, iNOS and COX2 [<xref rid="B41-molecules-25-04058" ref-type="bibr">41</xref>,<xref rid="B42-molecules-25-04058" ref-type="bibr">42</xref>,<xref rid="B43-molecules-25-04058" ref-type="bibr">43</xref>]. It has also been reported that selective inhibition of p38 or JNK downregulated TNF-&#x003b1; as well as other inflammatory mediators [<xref rid="B44-molecules-25-04058" ref-type="bibr">44</xref>]. These results imply that p38 and JNK MAPK signaling are deeply involved in TNF-&#x003b1; expression.</p></sec><sec id="sec2dot5-molecules-25-04058"><title>2.5. RAC Alleviates Xylene-Induced Mouse Ear Edema</title><p><italic>Xylene-</italic>induced ear edema is a simple and classic model for acute inflammation studies. It is widely used to evaluate the anti-inflammatory activities of substances [<xref rid="B16-molecules-25-04058" ref-type="bibr">16</xref>]. In this study, we assessed the anti-inflammatory effect of RAC on a xylene-induced ear edema model. The administration of PBS, dexamethasone and RAC did not affect intact ear weights (<xref ref-type="fig" rid="molecules-25-04058-f004">Figure 4</xref>A). The xylene application induced ear weight and differences in ear weight, but dexamethasone and RAC significantly decreased them compared with those of the xylene-only-treated group (<xref ref-type="fig" rid="molecules-25-04058-f004">Figure 4</xref>B,C).</p><p>Acute inflammation is initiated by the recognition of harmful stimuli by immune cells [<xref rid="B1-molecules-25-04058" ref-type="bibr">1</xref>,<xref rid="B2-molecules-25-04058" ref-type="bibr">2</xref>]. Immune cells, such as macrophages and mastocytes, release proinflammatory mediators like NO, PGE2, histamine, proinflammatory cytokines and chemokines. Histamine, NO and PGE2 cause vasodilation and increased vascular permeability through relaxing smooth muscle [<xref rid="B31-molecules-25-04058" ref-type="bibr">31</xref>,<xref rid="B45-molecules-25-04058" ref-type="bibr">45</xref>]. Proinflammatory cytokines and chemokines induce cell adhesion molecules, such as ICAM-1 and VCAM-1, recruit immune cells like neutrophils and leukocytes through chemotaxis [<xref rid="B46-molecules-25-04058" ref-type="bibr">46</xref>]. These responses cases immune cell infiltration and edema formation. In a histological analysis of the induced ear, xylene application induced severe vasodilation, edema formation, and immune cell infiltration. The dexamethasone and RAC treatments significantly reduced these factors and skin thickness compared with those of the xylene-only-treated groups (<xref ref-type="fig" rid="molecules-25-04058-f004">Figure 4</xref>D&#x02013;G). These results may be due to RAC-downregulated inflammatory mediators, which promote vasodilation and increase vascular permeability.</p></sec></sec><sec id="sec3-molecules-25-04058"><title>3. Materials and Methods</title><sec id="sec3dot1-molecules-25-04058"><title>3.1. Materials and Reagents</title><p>J774A.1 cells were purchased from the American Type Culture Collection (ATCC; Rockville, MD, USA). The cells were cultured in DMEM (Gibco BRL; Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS), 50 U/mL penicillin and 50 mg/mL streptomycin at 37 &#x000b0;C in a 5% CO<sub>2</sub> incubator. Thiazolyl blue tetrazolium bromide, Griess reagent and dexamethasone were obtained from Sigma Aldrich (St. Louis, MO, USA). All antibodies for immunoblot analysis were obtained from Cell Signaling Technology (Danvers, MA, USA).</p></sec><sec id="sec3dot2-molecules-25-04058"><title>3.2. Isolation of Retrofractamide C</title><p>Retrofractamide C was purified from the fruits of <italic>Piper longum</italic> as previously described [<xref rid="B22-molecules-25-04058" ref-type="bibr">22</xref>,<xref rid="B23-molecules-25-04058" ref-type="bibr">23</xref>]. In brief, dried fruits of <italic>Piper longum</italic> (100 g) were purchased at an herbal marker (Daejeon, Korea). The authenticity of the plant was confirmed by Prof. K. H. Bae, College of Pharmacy, Chungnam National University, Daejeon, Korea. Voucher specimens (PBC-413A and PBC-441A) were deposited in the Korea Plant Extract Bank, Korea Research Institute of Bioscience and Biotechnology. The dried fruits were extracted with methanol (MeOH, 1 L) for 7 days at room temperature. The MeOH extract was evaporated <italic>in vacuo</italic> to yield a residue (32 g). The residue was suspended in distilled water and extracted with chloroform. The chloroform-soluble fraction (7.5 g) was loaded onto a silica gel (230&#x02013;400 mesh, 1 kg, Merck, Darmstadt, Germany) column for chromatography and eluted with a stepwise gradient of increasing concentrations of chloroform/MeOH (100:0, 80:1, 60:1, 40:1, 20:1, 10:1, 5:1, and 1:1, each 3 L, v/v) to obtain eight subfractions (PLM1&#x02013;8) based on thin-layer chromatography (TLC) profiles. PLM1 was subjected to silica gel (230&#x02013;400 mesh, 400 g, Merck) column chromatography and fractionated with hexane/ethylacetate (EtOAc) (50:1, 20:1, 10:1, 7:1, 5:1, 3:1, and 1:1, each 2 L, v/v) to generate eight subfractions (PLM1A-H). PLM1A was separated by semipreparative HPLC (YMC J&#x02019;sphere ODS-H80 column, 4 &#x003bc;m, 250 &#x000d7; 20 mm, flow rate 4 mL/min) using isocratic elution with 80% MeOH in water to yield RAC (29.9 mg, retention time (tR) 39 min). The semipreparative HPLC consisted of a Shimadzu LC-6AD pump (Shimadzu, Tokyo, Japan) equipped with an SPD-10A detector (Shimadzu) using a YMC J&#x02019;sphere ODS-H80 column (YMC, Kyoto, Japan).</p></sec><sec id="sec3dot3-molecules-25-04058"><title>3.3. MTT Assay</title><p>J774A.1 cells were seeded in 96-well plates, treated with 1, 3 and 10 &#x003bc;M of RAC for 24 h and treated with thiazolyl blue tetrazolium bromide for 3 h. After incubation, the supernatant was removed, and the remaining formazan was dissolved in dimethyl sulfoxide (DMSO). The absorbance was measured at 540 nm using a microplate ELISA reader (Molecular Devices, Sunnyvale, CA, USA).</p></sec><sec id="sec3dot4-molecules-25-04058"><title>3.4. NO Assay</title><p>J774A.1 cells were cultured in 96-well plates and treated with 200 ng/mL LPS for 18 h after pretreatment with dexamethasone and RAC for 1 h. Then, the supernatant was collected and treated with Griess reagent. The absorbance was measured at 540 nm using a microplate ELISA reader.</p></sec><sec id="sec3dot5-molecules-25-04058"><title>3.5. ELISA</title><p>J774A.1 cells were seeded in 6-well plates and treated with 200 ng/mL LPS for 18 h after pretreatment with dexamethasone and RAC for 1 h. Then, the supernatant was collected, and the prostaglandin E2 (PGE2) concentration was measured by a mouse PGE2 ELISA kit (R&#x00026;D Systems, Minneapolis, MN, USA) following the manufacturer&#x02019;s instructions. The absorbance was measured at 450 nm using a microplate ELISA reader.</p></sec><sec id="sec3dot6-molecules-25-04058"><title>3.6. Quantitative Real-Time PCR</title><p>J774A.1 cells were seeded in 6-well plates, and cells were pretreated with the indicated concentrations of dexamethasone and RAC and then treated with 200 ng/mL LPS for 12 h. Total RNA was extracted by a PureLink RNA Mini Kit (Invitrogen, San Diego, CA, USA) following the manufacturer&#x02019;s instructions. Complementary DNA (cDNA) was synthesized using a PrimeScript 1st strand cDNA synthesis kit (Takara Bio Inc., Shiga, Japan) and subjected to quantitative real-time PCR. Quantitative real-time PCR was performed by a StepOnePlus Real-Time PCR S machine using a TaqMan probe and TaqMan PCR master mix (Applied Biosystems, Foster City, CA, USA).</p></sec><sec id="sec3dot7-molecules-25-04058"><title>3.7. Immunoblot Analysis</title><p>J774A.1 cells were seeded in 6-well plates and treated with 200 ng/mL LPS for the indicated times after pretreatment with dexamethasone and RAC for 1 h. Total proteins were extracted using cell lysis buffer supplemented with phosphatase and proteinase cocktail (Cell Signaling Technology). The total protein concentration was measured, and equal amounts of protein were subjected to 4&#x02013;12% SDS-PAGE. Separated proteins were transferred onto polyvinylidene fluoride (PVDF) membranes and blocked with tris-buffered saline (TBS) containing 5% skim milk. After blocking, the membrane was washed with TBS containing 0.1% Tween-20 (TBST) and incubated with the appropriate primary and secondary antibodies. Finally, the membrane was developed using a West-Queen RTS Western Blot Detection Kit (iNtRON Bio., Seongnam, Korea).</p></sec><sec id="sec3dot8-molecules-25-04058"><title>3.8. Animals and Induction of a Xylene-Induced Ear Edema Model</title><p>Detail procedures were described in a previous study [<xref rid="B47-molecules-25-04058" ref-type="bibr">47</xref>]. In brief, six-week-old male ICR mice were purchased from OrientBio (Kwangju, Korea) and randomly divided into 4 groups (<italic>n</italic> = 9 mice per group): PBS intraperitoneally injected and administered mice (Intact control), PBS intraperitoneally injected and xylene-administered mice (Xylene control), dexamethasone intraperitoneally injected and xylene-administered mice, and RAC orally administered and xylene-administered mice. Before 30 min of topical application of PBS or xylene on the anterior surface of the right ear for 2 h, the mice were administered PBS, 15 mg/kg dexamethasone intraperitoneally and 100 mg/kg RAC orally. After the topical application of 0.03 mL of PBS and xylene on the anterior surface of the right ear, the mice were sacrificed, and changes in ear weight and histopathology were measured. For histological analysis, mouse ears were fixed in 10% formalin, embedded in paraffin, sectioned and stained with hematoxylin and eosin (H&#x00026;E) following the general procedure. The experimental protocols were approved by the Institutional Animal Care and Use Committee of Korea Research Institute of Bioscience and Biotechnology (permission number KRIBB-AEC-17059). All mice were treated according to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.</p></sec><sec id="sec3dot9-molecules-25-04058"><title>3.9. Statistical Analysis</title><p>The results are presented as the mean &#x000b1; standard deviation (SD) of three or nine individual experiments. Statistical analysis was performed using Prism 5 software (GraphPad Software, San Diego, CA, USA) for in vitro results and one-way ANOVA followed by Tukey&#x02019;s test for in vivo results.</p></sec></sec><sec sec-type="conclusions" id="sec4-molecules-25-04058"><title>4. Conclusions</title><p>In this study, we evaluated the anti-inflammatory effect of RAC from <italic>Piper longum</italic> through in vitro and in vivo experiments. RAC decreased NO and PGE2 production and the protein expression of their synthesis enzymes. The gene expression of the IL-1&#x003b2; and IL-6 proinflammatory cytokines but not TNF-&#x003b1; expression was inhibited by RAC treatment. Immunoblot analysis of MAPKs and NF-&#x003ba;B signaling molecules showed specific inhibition of ERK and NF-&#x003ba;B p65 phosphorylation by RAC. Finally, RAC treatment alleviated xylene-induced ear edema. Taken together with our previous research on the inhibitory activity on cell adhesion, the present results confirm the anti-inflammatory activity of RAC. Based on our results, this alkamide could be a useful candidate for anti-inflammatory agent development.</p></sec></body><back><fn-group><fn><p><bold>Sample Availability:</bold> Samples of the compounds are not available from the authors.</p></fn></fn-group><notes><title>Author Contributions</title><p>H.J.L., E.J.P. and S.G.B. performed the experiments and analyzed the data; S.W.L. and S.L. contributed reagents, materials, and analysis tools; S.-K.K. and K.M.L. conceived and designed the experiments; and S.-J.L. and M.-C.R. contributed to conceptualization, writing, editing. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2019R1A2C2087608). This research was a part of the project titled &#x02018;Development of material for improving menopausal symptoms using callus-based <italic>Colpomenia sinuosa</italic>&#x02019;, funded by the Ministry of Oceans and Fisheries, Korea and KRIBB Research Initiative Program (KGM5242012).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>We declare that we have no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-25-04058"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>H.</given-names></name><name><surname>Cui</surname><given-names>H.</given-names></name><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Zuo</surname><given-names>Z.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name></person-group><article-title>Inflammatory responses and inflammation-associated diseases in organs</article-title><source>Oncotarget</source><year>2018</year><volume>9</volume><fpage>7204</fpage><lpage>7218</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.23208</pub-id><pub-id pub-id-type="pmid">29467962</pub-id></element-citation></ref><ref id="B2-molecules-25-04058"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chovatiya</surname><given-names>R.</given-names></name><name><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group><article-title>Stress, inflammation, and defense of homeostasis</article-title><source>Mol. Cell</source><year>2004</year><volume>54</volume><fpage>281</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.03.030</pub-id><pub-id pub-id-type="pmid">24766892</pub-id></element-citation></ref><ref id="B3-molecules-25-04058"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>H.</given-names></name><name><surname>Higashiura</surname><given-names>Y.</given-names></name><name><surname>Shigetomi</surname><given-names>H.</given-names></name><name><surname>Kajihara</surname><given-names>H.</given-names></name></person-group><article-title>Pathogenesis of endometriosis: The role of initial infection and subsequent sterile inflammation</article-title><source>Mol. Med. Rep.</source><year>2014</year><volume>9</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.3892/mmr.2013.1755</pub-id><pub-id pub-id-type="pmid">24173432</pub-id></element-citation></ref><ref id="B4-molecules-25-04058"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton</surname><given-names>K.</given-names></name><name><surname>Dixit</surname><given-names>V.M.</given-names></name></person-group><article-title>Signaling in innate immunity and inflammation</article-title><source>Cold Spring Harb. Perspect. Biol.</source><year>2012</year><volume>4</volume><fpage>a006049</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a006049</pub-id><pub-id pub-id-type="pmid">22296764</pub-id></element-citation></ref><ref id="B5-molecules-25-04058"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergallo</surname><given-names>M.</given-names></name><name><surname>Galliano</surname><given-names>I.</given-names></name><name><surname>Montanari</surname><given-names>P.</given-names></name><name><surname>Calvi</surname><given-names>C.</given-names></name><name><surname>Rassu</surname><given-names>M.</given-names></name><name><surname>Dapra</surname><given-names>V.</given-names></name></person-group><article-title>Toll-like receptor 9 gene polymorphisms rs352140 confer susceptibility to graft-versus-host disease in allogenic hematopoietic stem cell transplantation</article-title><source>Minerva Biotecnol.</source><year>2019</year><volume>31</volume><fpage>49</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.23736/S1120-4826.18.02484-9</pub-id></element-citation></ref><ref id="B6-molecules-25-04058"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>T.</given-names></name><name><surname>Kawai</surname><given-names>T.</given-names></name></person-group><article-title>Toll-like receptor signaling pathways</article-title><source>Front. Immunol.</source><year>2014</year><volume>5</volume><fpage>461</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2014.00461</pub-id><pub-id pub-id-type="pmid">25309543</pub-id></element-citation></ref><ref id="B7-molecules-25-04058"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujioka</surname><given-names>S.</given-names></name><name><surname>Niu</surname><given-names>J.</given-names></name><name><surname>Schmidt</surname><given-names>C.</given-names></name><name><surname>Sclabas</surname><given-names>G.M.</given-names></name><name><surname>Peng</surname><given-names>B.</given-names></name><name><surname>Uwagawa</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Evans</surname><given-names>D.B.</given-names></name><name><surname>Abbruzzese</surname><given-names>J.L.</given-names></name><name><surname>Chiao</surname><given-names>P.J.</given-names></name></person-group><article-title>NF-&#x003ba;B and AP-1 connection: Mechanism of NF-&#x003ba;B-dependent regulation of AP-1 activity</article-title><source>Mol. Cell. Boil.</source><year>2004</year><volume>24</volume><fpage>7806</fpage><lpage>7819</lpage><pub-id pub-id-type="doi">10.1128/MCB.24.17.7806-7819.2004</pub-id></element-citation></ref><ref id="B8-molecules-25-04058"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalaf</surname><given-names>H.</given-names></name><name><surname>Jass</surname><given-names>J.</given-names></name><name><surname>Olsson</surname><given-names>P.E.</given-names></name></person-group><article-title>Differential cytokine regulation by NF-&#x003ba;B and AP-1 in Jurkat T-cells</article-title><source>BMC Immunol.</source><year>2010</year><volume>11</volume><elocation-id>26</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2172-11-26</pub-id><pub-id pub-id-type="pmid">20507572</pub-id></element-citation></ref><ref id="B9-molecules-25-04058"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatia</surname><given-names>M.</given-names></name><name><surname>Moochhala</surname><given-names>S.</given-names></name></person-group><article-title>Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome</article-title><source>J. Pathol.</source><year>2004</year><volume>202</volume><fpage>145</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1002/path.1491</pub-id><pub-id pub-id-type="pmid">14743496</pub-id></element-citation></ref><ref id="B10-molecules-25-04058"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Joo</surname><given-names>D.</given-names></name><name><surname>Sun</surname><given-names>S.C.</given-names></name></person-group><article-title>NF-&#x003ba;B signaling in inflammation</article-title><source>Signal Transduct. Target. Ther.</source><year>2017</year><volume>2</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/sigtrans.2017.23</pub-id></element-citation></ref><ref id="B11-molecules-25-04058"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djukanovic</surname><given-names>R.</given-names></name><name><surname>Wilson</surname><given-names>S.J.</given-names></name><name><surname>Kraft</surname><given-names>M.</given-names></name><name><surname>Jarjour</surname><given-names>N.N.</given-names></name><name><surname>Steel</surname><given-names>M.</given-names></name><name><surname>Chung</surname><given-names>K.F.</given-names></name><name><surname>Bao</surname><given-names>W.</given-names></name><name><surname>Fowler-Taylor</surname><given-names>A.</given-names></name><name><surname>Matthews</surname><given-names>J.</given-names></name><name><surname>Busse</surname><given-names>W.W.</given-names></name><etal/></person-group><article-title>Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma</article-title><source>Am. J. Respir. Crit. Care Med.</source><year>2004</year><volume>170</volume><fpage>583</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1164/rccm.200312-1651OC</pub-id><pub-id pub-id-type="pmid">15172898</pub-id></element-citation></ref><ref id="B12-molecules-25-04058"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>Y.B.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Han</surname><given-names>H.J.</given-names></name><name><surname>Mar</surname><given-names>W.C.</given-names></name><name><surname>Kang</surname><given-names>S.K.</given-names></name><name><surname>Yoon</surname><given-names>O.B.</given-names></name><name><surname>Beitz</surname><given-names>A.J.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name></person-group><article-title>The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats</article-title><source>Life Sci.</source><year>2002</year><volume>71</volume><fpage>191</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/S0024-3205(02)01617-X</pub-id><pub-id pub-id-type="pmid">12031688</pub-id></element-citation></ref><ref id="B13-molecules-25-04058"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>L.</given-names></name><name><surname>Feng</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Z.H.</given-names></name><name><surname>Jia</surname><given-names>X.B.</given-names></name></person-group><article-title>The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-&#x003ba;B pathway activation</article-title><source>Int. Immunopharmacol.</source><year>2014</year><volume>23</volume><fpage>294</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2014.09.005</pub-id><pub-id pub-id-type="pmid">25239813</pub-id></element-citation></ref><ref id="B14-molecules-25-04058"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>B.D.</given-names></name><name><surname>Natanson</surname><given-names>C.</given-names></name></person-group><article-title>Anti-inflammatory therapies in sepsis and septic shock</article-title><source>Expert Opin. Inv. Drug.</source><year>2000</year><volume>9</volume><fpage>1651</fpage><lpage>1663</lpage><pub-id pub-id-type="doi">10.1517/13543784.9.7.1651</pub-id></element-citation></ref><ref id="B15-molecules-25-04058"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segura</surname><given-names>M.</given-names></name><name><surname>Vadeboncoeur</surname><given-names>N.</given-names></name><name><surname>Gottschalk</surname><given-names>M.</given-names></name></person-group><article-title>CD14-dependent and-independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2</article-title><source>Clin. Exp. Immunol.</source><year>2002</year><volume>127</volume><fpage>243</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2249.2002.01768.x</pub-id><pub-id pub-id-type="pmid">11876746</pub-id></element-citation></ref><ref id="B16-molecules-25-04058"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.L.</given-names></name><name><surname>Li</surname><given-names>Y.X.</given-names></name><name><surname>Niu</surname><given-names>Y.T.</given-names></name><name><surname>Zheng</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>G.J.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Niu</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>J.Q.</given-names></name></person-group><article-title>Observing anti-inflammatory and anti-nociceptive activities of glycyrrhizin through regulating COX-2 and pro-inflammatory cytokines expressions in mice</article-title><source>Inflammation</source><year>2015</year><volume>38</volume><fpage>2269</fpage><lpage>2278</lpage><pub-id pub-id-type="doi">10.1007/s10753-015-0212-3</pub-id><pub-id pub-id-type="pmid">26178479</pub-id></element-citation></ref><ref id="B17-molecules-25-04058"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunasekar</surname><given-names>P.G.</given-names></name><name><surname>Rogers</surname><given-names>J.V.</given-names></name><name><surname>Kabbur</surname><given-names>M.B.</given-names></name><name><surname>Garrett</surname><given-names>C.M.</given-names></name><name><surname>Brinkley</surname><given-names>W.W.</given-names></name><name><surname>McDougal</surname><given-names>J.N.</given-names></name></person-group><article-title>Molecular and histological responses in rat skin exposed to m-xylene</article-title><source>J. Biochem. Mol. Toxicol.</source><year>2003</year><volume>17</volume><fpage>92</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1002/jbt.10065</pub-id><pub-id pub-id-type="pmid">12717741</pub-id></element-citation></ref><ref id="B18-molecules-25-04058"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>J.V.</given-names></name><name><surname>Gunasekar</surname><given-names>P.G.</given-names></name><name><surname>Garrett</surname><given-names>C.M.</given-names></name><name><surname>McDougal</surname><given-names>J.N.</given-names></name></person-group><article-title>Dermal exposure to m-xylene leads to increasing oxidative species and low molecular weight dna levels in rat skin</article-title><source>J. Biochem. Mol. Toxicol.</source><year>2001</year><volume>15</volume><fpage>228</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1002/jbt.21</pub-id><pub-id pub-id-type="pmid">11673852</pub-id></element-citation></ref><ref id="B19-molecules-25-04058"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahaghotu</surname><given-names>E.</given-names></name><name><surname>Babu</surname><given-names>R.J.</given-names></name><name><surname>Chatterjee</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>M.</given-names></name></person-group><article-title>Effect of methyl substitution of benzene on the percutaneous absorption and skin irritation in hairless rats</article-title><source>Toxicol. Lett.</source><year>2005</year><volume>159</volume><fpage>261</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2005.05.020</pub-id><pub-id pub-id-type="pmid">16087301</pub-id></element-citation></ref><ref id="B20-molecules-25-04058"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghoshal</surname><given-names>S.</given-names></name><name><surname>Prasad</surname><given-names>B.K.</given-names></name><name><surname>Lakshmi</surname><given-names>V.</given-names></name></person-group><article-title>Antiamoebic activity of Piper longum fruits against Entamoeba histolytica in vitro and in vivo</article-title><source>J. Ethnopharmacol.</source><year>1996</year><volume>50</volume><fpage>167</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(96)01382-7</pub-id><pub-id pub-id-type="pmid">8691851</pub-id></element-citation></ref><ref id="B21-molecules-25-04058"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>B.S.</given-names></name><name><surname>Son</surname><given-names>D.J.</given-names></name><name><surname>Park</surname><given-names>Y.H.</given-names></name><name><surname>Kim</surname><given-names>T.W.</given-names></name><name><surname>Lee</surname><given-names>S.E.</given-names></name></person-group><article-title>Antiplatelet effects of acidamides isolated from the fruits of Piper longum L.</article-title><source>Phytomedicine</source><year>2007</year><volume>14</volume><fpage>853</fpage><lpage>855</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2007.06.011</pub-id><pub-id pub-id-type="pmid">17689230</pub-id></element-citation></ref><ref id="B22-molecules-25-04058"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salehi</surname><given-names>B.</given-names></name><name><surname>Zakaria</surname><given-names>Z.A.</given-names></name><name><surname>Gyawali</surname><given-names>R.</given-names></name><name><surname>Ibrahim</surname><given-names>S.A.</given-names></name><name><surname>Rajkovic</surname><given-names>J.</given-names></name><name><surname>Shinwari</surname><given-names>Z.K.</given-names></name><name><surname>Khan</surname><given-names>T.</given-names></name><name><surname>Sharifi-Rad</surname><given-names>J.</given-names></name><name><surname>Ozleyen</surname><given-names>A.</given-names></name><name><surname>Turkdonmez</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Piper species: A comprehensive review on their phytochemistry, biological activities and applications</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1364</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24071364</pub-id><pub-id pub-id-type="pmid">30959974</pub-id></element-citation></ref><ref id="B23-molecules-25-04058"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>K.S.</given-names></name><name><surname>Oh</surname><given-names>Y.N.</given-names></name><name><surname>Lee</surname><given-names>J.Y.</given-names></name><name><surname>Son</surname><given-names>B.Y.</given-names></name><name><surname>Choi</surname><given-names>W.</given-names></name><name><surname>Lee</surname><given-names>E.W.</given-names></name><name><surname>Kwon</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>B.W.</given-names></name></person-group><article-title>Anti-oxidative and anti-inflammatory activities of seven medicinal herbs including Tetrapanax papyriferus and Piper longum Linne</article-title><source>Microbiol. Biotechnol. Lett.</source><year>2013</year><volume>41</volume><fpage>253</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.4014/kjmb.1207.07022</pub-id></element-citation></ref><ref id="B24-molecules-25-04058"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.C.</given-names></name><name><surname>Lee</surname><given-names>S.G.</given-names></name><name><surname>Lee</surname><given-names>H.K.</given-names></name><name><surname>Kim</surname><given-names>M.K.</given-names></name><name><surname>Lee</surname><given-names>S.H.</given-names></name><name><surname>Lee</surname><given-names>H.S.</given-names></name></person-group><article-title>A piperidine amide extracted from Piper longum L. fruit shows activity against Aedes aegypti mosquito larvae</article-title><source>J. Agric. Food Chem.</source><year>2002</year><volume>50</volume><fpage>3765</fpage><lpage>3767</lpage><pub-id pub-id-type="doi">10.1021/jf011708f</pub-id><pub-id pub-id-type="pmid">12059157</pub-id></element-citation></ref><ref id="B25-molecules-25-04058"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joy</surname><given-names>B.</given-names></name><name><surname>Sandhya</surname><given-names>C.P.</given-names></name><name><surname>Remitha</surname><given-names>K.R.</given-names></name></person-group><article-title>Comparison and bioevaluation of Piper longum fruit extracts</article-title><source>J. Chem. Pharm. Res.</source><year>2010</year><volume>2</volume><fpage>612</fpage><lpage>622</lpage></element-citation></ref><ref id="B26-molecules-25-04058"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khushbu</surname><given-names>C.</given-names></name><name><surname>Roshni</surname><given-names>S.</given-names></name><name><surname>Anar</surname><given-names>P.</given-names></name><name><surname>Carol</surname><given-names>M.</given-names></name><name><surname>Mayuree</surname><given-names>P.</given-names></name></person-group><article-title>Phytochemical and therapeutic potential of Piper longum Linn a review</article-title><source>Int. J. Res. Ayurveda Pharm.</source><year>2011</year><volume>2</volume><fpage>157</fpage><lpage>161</lpage></element-citation></ref><ref id="B27-molecules-25-04058"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.W.</given-names></name><name><surname>Rho</surname><given-names>M.C.</given-names></name><name><surname>Park</surname><given-names>H.R.</given-names></name><name><surname>Choi</surname><given-names>J.H.</given-names></name><name><surname>Kang</surname><given-names>J.Y.</given-names></name><name><surname>Lee</surname><given-names>J.W.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>Y.K.</given-names></name></person-group><article-title>Inhibition of diacylglycerol acyltransferase by alkamides isolated from the fruits of Piper longum and Piper nigrum</article-title><source>J. Agric. Food Chem.</source><year>2006</year><volume>54</volume><fpage>9759</fpage><lpage>9763</lpage><pub-id pub-id-type="doi">10.1021/jf061402e</pub-id><pub-id pub-id-type="pmid">17177498</pub-id></element-citation></ref><ref id="B28-molecules-25-04058"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.W.</given-names></name><name><surname>Kim</surname><given-names>Y.K.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>H.S.</given-names></name><name><surname>Choi</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>W.S.</given-names></name><name><surname>Jun</surname><given-names>C.D.</given-names></name><name><surname>Park</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>J.M.</given-names></name><name><surname>Rho</surname><given-names>M.C.</given-names></name></person-group><article-title>Alkamides from the fruits of Piper longum and Piper nigrum displaying potent cell adhesion inhibition</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2008</year><volume>18</volume><fpage>4544</fpage><lpage>4546</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2008.07.045</pub-id><pub-id pub-id-type="pmid">18672369</pub-id></element-citation></ref><ref id="B29-molecules-25-04058"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okumura</surname><given-names>Y.</given-names></name><name><surname>Narukawa</surname><given-names>M.</given-names></name><name><surname>Iwasaki</surname><given-names>Y.</given-names></name><name><surname>Ishikawa</surname><given-names>A.</given-names></name><name><surname>Matsuda</surname><given-names>H.</given-names></name><name><surname>Yoshikawa</surname><given-names>M.</given-names></name><name><surname>Watanabe</surname><given-names>T.</given-names></name></person-group><article-title>Activation of TRPV1 and TRPA1 by black pepper components</article-title><source>Biosci. Biotech. Bioch.</source><year>2010</year><volume>74</volume><fpage>1068</fpage><lpage>1072</lpage><pub-id pub-id-type="doi">10.1271/bbb.90964</pub-id></element-citation></ref><ref id="B30-molecules-25-04058"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>P.</given-names></name><name><surname>Tripathi</surname><given-names>P.</given-names></name><name><surname>Kashyap</surname><given-names>L.</given-names></name><name><surname>Singh</surname><given-names>V.</given-names></name></person-group><article-title>The role of nitric oxide in inflammatory reactions</article-title><source>FEMS Immunol. Med. Microbiol.</source><year>2007</year><volume>51</volume><fpage>443</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1111/j.1574-695X.2007.00329.x</pub-id><pub-id pub-id-type="pmid">17903207</pub-id></element-citation></ref><ref id="B31-molecules-25-04058"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricciotti</surname><given-names>E.</given-names></name><name><surname>FitzGerald</surname><given-names>G.A.</given-names></name></person-group><article-title>Prostaglandins and inflammation</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><year>2011</year><volume>31</volume><fpage>986</fpage><lpage>1000</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.110.207449</pub-id><pub-id pub-id-type="pmid">21508345</pub-id></element-citation></ref><ref id="B32-molecules-25-04058"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luiking</surname><given-names>Y.C.</given-names></name><name><surname>Engelen</surname><given-names>M.P.</given-names></name><name><surname>Deutz</surname><given-names>N.E.</given-names></name></person-group><article-title>Regulation of nitric oxide production in health and disease</article-title><source>Curr. Opin. Clin. Nutr. Metab. Care</source><year>2010</year><volume>13</volume><fpage>97</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1097/MCO.0b013e328332f99d</pub-id><pub-id pub-id-type="pmid">19841582</pub-id></element-citation></ref><ref id="B33-molecules-25-04058"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mardini</surname><given-names>I.A.</given-names></name><name><surname>FitzGerald</surname><given-names>G.A.</given-names></name></person-group><article-title>Selective inhibitors of cyclooxygenase-2: A growing class of anti-inflammatory drugs</article-title><source>Mol. Interv.</source><year>2001</year><volume>1</volume><fpage>30</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">14993336</pub-id></element-citation></ref><ref id="B34-molecules-25-04058"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caiello</surname><given-names>I.</given-names></name><name><surname>Minnone</surname><given-names>G.</given-names></name><name><surname>Holzinger</surname><given-names>D.</given-names></name><name><surname>Vogl</surname><given-names>T.</given-names></name><name><surname>Prencipe</surname><given-names>G.</given-names></name><name><surname>Manzo</surname><given-names>A.</given-names></name><name><surname>Benedetti</surname><given-names>F.D.</given-names></name><name><surname>Strippoli</surname><given-names>R.</given-names></name></person-group><article-title>IL-6 amplifies TLR mediated cytokine and chemokine production: Implications for the pathogenesis of rheumatic inflammatory diseases</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e107886</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0107886</pub-id><pub-id pub-id-type="pmid">25271853</pub-id></element-citation></ref><ref id="B35-molecules-25-04058"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saferding</surname><given-names>V.</given-names></name><name><surname>Bl&#x000fc;ml</surname><given-names>S.</given-names></name></person-group><article-title>Innate immunity as the trigger of systemic autoimmune diseases</article-title><source>J. Autoimmun.</source><year>2020</year><volume>110</volume><fpage>102382</fpage><pub-id pub-id-type="doi">10.1016/j.jaut.2019.102382</pub-id><pub-id pub-id-type="pmid">31883831</pub-id></element-citation></ref><ref id="B36-molecules-25-04058"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McInnes</surname><given-names>I.B.</given-names></name><name><surname>Schett</surname><given-names>G.</given-names></name></person-group><article-title>Cytokines in the pathogenesis of rheumatoid arthritis</article-title><source>Nat. Rev. Immunol.</source><year>2007</year><volume>7</volume><fpage>429</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1038/nri2094</pub-id><pub-id pub-id-type="pmid">17525752</pub-id></element-citation></ref><ref id="B37-molecules-25-04058"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Lim</surname><given-names>H.J.</given-names></name><name><surname>Jang</surname><given-names>H.J.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Jung</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>S.W.</given-names></name><name><surname>Lee</surname><given-names>S.J.</given-names></name><name><surname>Rho</surname><given-names>M.C.</given-names></name></person-group><article-title>Portulaca oleracea extracts and their active compounds ameliorate inflammatory bowel diseases in vitro and in vivo by modulating TNF-&#x003b1;, IL-6 and IL-1&#x003b2; signalling</article-title><source>Food Res. Int.</source><year>2018</year><volume>106</volume><fpage>335</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2017.12.058</pub-id><pub-id pub-id-type="pmid">29579933</pub-id></element-citation></ref><ref id="B38-molecules-25-04058"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommer</surname><given-names>C.</given-names></name><name><surname>Kress</surname><given-names>M.</given-names></name></person-group><article-title>Recent findings on how proinflammatory cytokines cause pain: Peripheral mechanisms in inflammatory and neuropathic hyperalgesia</article-title><source>Neurosci. Lett.</source><year>2004</year><volume>361</volume><fpage>184</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2003.12.007</pub-id><pub-id pub-id-type="pmid">15135924</pub-id></element-citation></ref><ref id="B39-molecules-25-04058"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>P.</given-names></name><name><surname>Phillips</surname><given-names>K.</given-names></name><name><surname>Stoecklin</surname><given-names>G.</given-names></name><name><surname>Kedersha</surname><given-names>N.</given-names></name></person-group><article-title>Post-transcriptional regulation of proinflammatory proteins</article-title><source>J. Leukoc. Biol.</source><year>2004</year><volume>76</volume><fpage>42</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1189/jlb.1103536</pub-id><pub-id pub-id-type="pmid">15075353</pub-id></element-citation></ref><ref id="B40-molecules-25-04058"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mino</surname><given-names>T.</given-names></name><name><surname>Takeuchi</surname><given-names>O.</given-names></name></person-group><article-title>Post-transcriptional regulation of cytokine mRNA controls the initiation and resolution of inflammation</article-title><source>Biotechnol. Genet. Eng. Rev.</source><year>2013</year><volume>29</volume><fpage>49</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1080/02648725.2013.801236</pub-id><pub-id pub-id-type="pmid">24568252</pub-id></element-citation></ref><ref id="B41-molecules-25-04058"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>H.J.</given-names></name><name><surname>Bak</surname><given-names>S.G.</given-names></name><name><surname>Lim</surname><given-names>H.J.</given-names></name><name><surname>Lee</surname><given-names>S.W.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Ku</surname><given-names>S.K.</given-names></name><name><surname>Park</surname><given-names>S.I.</given-names></name><name><surname>Lee</surname><given-names>S.J.</given-names></name><name><surname>Rho</surname><given-names>M.C.</given-names></name></person-group><article-title>Acyclic Triterpenoid Isolated from Alpinia katsumadai Alleviates Formalin-Induced Chronic Mouse Paw Inflammation by Inhibiting the Phosphorylation of ERK and NF-&#x003ba;B</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>3345</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25153345</pub-id></element-citation></ref><ref id="B42-molecules-25-04058"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.Y.</given-names></name><name><surname>Lim</surname><given-names>M.S.</given-names></name><name><surname>Kim</surname><given-names>S.I.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>S.S.</given-names></name><name><surname>Kwon</surname><given-names>Y.S.</given-names></name><name><surname>Chun</surname><given-names>W.</given-names></name></person-group><article-title>Quercetin-3-O-&#x003b2;-D-glucuronide suppresses lipopolysaccharide-induced JNK and ERK phosphorylation in LPS-challenged RAW264. 7 cells</article-title><source>Biomol. Ther.</source><year>2016</year><volume>24</volume><fpage>610</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.4062/biomolther.2016.026</pub-id></element-citation></ref><ref id="B43-molecules-25-04058"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.N.</given-names></name><name><surname>Shin</surname><given-names>S.A.</given-names></name><name><surname>Choo</surname><given-names>G.S.</given-names></name><name><surname>Kim</surname><given-names>H.J.</given-names></name><name><surname>Park</surname><given-names>Y.S.</given-names></name><name><surname>Kim</surname><given-names>B.S.</given-names></name><name><surname>Kim</surname><given-names>S.K.</given-names></name><name><surname>Cho</surname><given-names>S.D.</given-names></name><name><surname>Nam</surname><given-names>J.S.</given-names></name><name><surname>Choi</surname><given-names>C.S.</given-names></name><etal/></person-group><article-title>Anti-inflammatory effect of quercetin and galangin in LPS-stimulated RAW264. 7 macrophages and DNCB-induced atopic dermatitis animal models</article-title><source>Int. J. Mol. Med.</source><year>2018</year><volume>41</volume><fpage>888</fpage><lpage>898</lpage><pub-id pub-id-type="pmid">29207037</pub-id></element-citation></ref><ref id="B44-molecules-25-04058"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uesugi</surname><given-names>M.</given-names></name><name><surname>Nakajima</surname><given-names>K.</given-names></name><name><surname>Tohyama</surname><given-names>Y.</given-names></name><name><surname>Kohsaka</surname><given-names>S.</given-names></name><name><surname>Kurihara</surname><given-names>T.</given-names></name></person-group><article-title>Nonparticipation of nuclear factor kappa B (NF&#x003ba;B) in the signaling cascade of c-Jun N-terminal kinase (JNK)-and p38 mitogen-activated protein kinase (p38MAPK)-dependent tumor necrosis factor alpha (TNF&#x003b1;) induction in lipopolysaccharide (LPS)-stimulated microglia</article-title><source>Brain Res. J.</source><year>2006</year><volume>1073</volume><fpage>48</fpage><lpage>59</lpage></element-citation></ref><ref id="B45-molecules-25-04058"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashina</surname><given-names>K.</given-names></name><name><surname>Tsubosaka</surname><given-names>Y.</given-names></name><name><surname>Nakamura</surname><given-names>T.</given-names></name><name><surname>Omori</surname><given-names>K.</given-names></name><name><surname>Kobayashi</surname><given-names>K.</given-names></name><name><surname>Hori</surname><given-names>M.</given-names></name><name><surname>Ozaki</surname><given-names>H.</given-names></name><name><surname>Murata</surname><given-names>T.</given-names></name></person-group><article-title>Histamine induces vascular hyperpermeability by increasing blood flow and endothelial barrier disruption in vivo</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0132367</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0132367</pub-id><pub-id pub-id-type="pmid">26158531</pub-id></element-citation></ref><ref id="B46-molecules-25-04058"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radi</surname><given-names>Z.A.</given-names></name><name><surname>Kehrli</surname><given-names>M.E.</given-names><suffix>Jr.</suffix></name><name><surname>Ackermann</surname><given-names>M.R.</given-names></name></person-group><article-title>Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration</article-title><source>J. Vet. Intern. Med.</source><year>2001</year><volume>15</volume><fpage>516</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1111/j.1939-1676.2001.tb01586.x</pub-id><pub-id pub-id-type="pmid">11817056</pub-id></element-citation></ref><ref id="B47-molecules-25-04058"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Back</surname><given-names>Y.D.</given-names></name><name><surname>Lee</surname><given-names>H.S.</given-names></name><name><surname>Ku</surname><given-names>S.K.</given-names></name></person-group><article-title>Effects of DHU001, a mixed herbal formula on acute inflammation in mice</article-title><source>Toxicol. Res.</source><year>2008</year><volume>24</volume><fpage>189</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.5487/TR.2008.24.3.189</pub-id><pub-id pub-id-type="pmid">32038794</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-25-04058-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Inhibitory effect of retrofractamide C (RAC) on lipopolysaccharide (LPS)-induced nitric oxide (NO) and PGE2 production and iNOS and COX2 protein expression in J774A.1 cells. (<bold>A</bold>) Chemical structure of retrofractamide C (RAC). (<bold>B</bold>) Cytotoxicity of RAC. J774A.1 cells were treated with the indicated concentrations of dexamethasone and RAC for 24 h. Cytotoxicity was determined by MTT assay. (<bold>C</bold>,<bold>D</bold>) Inhibition of NO and PGE2 production by RAC. J774A.1 cells were pretreated with 10 &#x003bc;M dexamethasone or 1, 3 or 10 &#x003bc;M RAC for 1 h before treatment with 200 ng/mL LPS for 18 h. (<bold>C</bold>) The secretion of NO was measured by an NO assay. (<bold>D</bold>) PGE2 production was determined by ELISA. (<bold>E</bold>) iNOS and COX2 protein expression decreased by RAC treatment. J774A.1 cells were treated with 200 ng/mL LPS for 18 h after treatment with dexamethasone and RAC for 1 h. The iNOS and COX2 protein expression levels were determined by immunoblot assay. The band optical densities were calculated by ImageJ software. Representative data are presented. Values are presented as the mean &#x000b1; SD of three individual experiments. * <italic>p</italic> &#x0003c; 0.05, ** <italic>p</italic> &#x0003c; 0.01 compared with the LPS only-treated group. DEX, 10 &#x003bc;M dexamethasone.</p></caption><graphic xlink:href="molecules-25-04058-g001"/></fig><fig id="molecules-25-04058-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Effect of RAC on LPS-induced proinflammatory gene expression. J774A.1 cells were treated with 200 ng/mL LPS after pretreatment with 10 &#x003bc;M dexamethasone or 1, 3 or 10 &#x003bc;M RAC for 1 h. (<bold>A</bold>) IL-1&#x003b2;, (<bold>B</bold>) IL-6 and (<bold>C</bold>) TNF-&#x003b1; gene expression was determined by quantitative real-time PCR. The data were normalized to 18S rRNA expression and are presented as the fold change compared to the untreated group. The results are presented as the mean &#x000b1; SD of three individual experiments. * <italic>p</italic> &#x0003c; 0.05, ** <italic>p</italic> &#x0003c; 0.01 compared with the LPS only-treated group. DEX, 10 &#x003bc;M dexamethasone.</p></caption><graphic xlink:href="molecules-25-04058-g002"/></fig><fig id="molecules-25-04058-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Effect of RAC on LPS-induced MAPKs and the NF-&#x003ba;B signaling pathway. J774A.1 cells were pretreated with 10 &#x003bc;M dexamethasone or 1, 3 or 10 &#x003bc;M RAC for 1 h before treatment with 200 ng/mL LPS for 30 min to 1 h. (<bold>A</bold>) The protein expression of MAPKs was determined by immunoblot. Band optical densities were calculated by ImageJ software. (<bold>B</bold>) NF-&#x003ba;B p65 subunit expression was measured by immunoblot analysis, and the band optical density was calculated by ImageJ software. The results are representative of three independent experiments. Values are presented as the mean &#x000b1; SD of three individual experiments. * <italic>p</italic> &#x0003c; 0.05, ** <italic>p</italic> &#x0003c; 0.01 compared with the LPS only-treated group.</p></caption><graphic xlink:href="molecules-25-04058-g003"/></fig><fig id="molecules-25-04058-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Effect of RAC on the xylene-induced mouse ear edema model. The mice were pretreated with PBS or dexamethasone (15 mg/kg) intraperitoneally or RAC (100 mg/kg) orally before xylene application on the anterior surface of the right ear for 2 h. (<bold>A</bold>) Intact ear weight, (<bold>B</bold>) induced ear weight and (<bold>C</bold>) differences in ear weight were measured. (<bold>D</bold>&#x02013;<bold>G</bold>) For histological analysis, mouse ears were fixed and stained with H&#x00026;E. (<bold>D</bold>) Representative H&#x00026;E-stained mouse ear images of each group. Severe vasodilation (asterisks) and infiltration of inflammatory cells (arrows) were observed in the xylene only-treated group. (<bold>E</bold>) Anterior skin thickness, (<bold>F</bold>) full ear thickness and (<bold>G</bold>) the number of infiltrated inflammatory cells were measured. Values are presented as the mean &#x000b1; SD of nine experimental individuals. * <italic>p</italic> &#x0003c; 0.05, ** <italic>p</italic> &#x0003c; 0.01 compared with the xylene-only-treated group. ad, adipocytes; co, chondrocytes. Scale bars represent 80 &#x003bc;m.</p></caption><graphic xlink:href="molecules-25-04058-g004"/></fig></floats-group></article>